Glut1 deficiency (G1D): Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype

Isaac Marin-Valencia, Levi B. Good, Qian Ma, Joao Duarte, Teodoro Bottiglieri, Christopher M. Sinton, Charles W. Heilig, Juan M. Pascual

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Brain glucose supplies most of the carbon required for acetyl-coenzyme A (acetyl-CoA) generation (an important step for myelin synthesis) and for neurotransmitter production via further metabolism of acetyl-CoA in the tricarboxylic acid (TCA) cycle. However, it is not known whether reduced brain glucose transporter type I (GLUT-1) activity, the hallmark of the GLUT-1 deficiency (G1D) syndrome, leads to acetyl-CoA, TCA or neurotransmitter depletion. This question is relevant because, in its most common form in man, G1D is associated with cerebral hypomyelination (manifested as microcephaly) and epilepsy, suggestive of acetyl-CoA depletion and neurotransmitter dysfunction, respectively. Yet, brain metabolism in G1D remains underexplored both theoretically and experimentally, partly because computational models of limited brain glucose transport are subordinate to metabolic assumptions and partly because current hemizygous G1D mouse models manifest a mild phenotype not easily amenable to investigation. In contrast, adult antisense G1D mice replicate the human phenotype of spontaneous epilepsy associated with robust thalamocortical electrical oscillations. Additionally, and in consonance with human metabolic imaging observations, thalamus and cerebral cortex display the lowest GLUT-1 expression and glucose uptake in the mutant mouse. This depletion of brain glucose is associated with diminished plasma fatty acids and elevated ketone body levels, and with decreased brain acetyl-CoA and fatty acid contents, consistent with brain ketone body consumption and with stimulation of brain beta-oxidation and/or diminished cerebral lipid synthesis. In contrast with other epilepsies, astrocyte glutamine synthetase expression, cerebral TCA cycle intermediates, amino acid and amine neurotransmitter contents are also intact in G1D. The data suggest that the TCA cycle is preserved in G1D because reduced glycolysis and acetyl-CoA formation can be balanced by enhanced ketone body utilization. These results are incompatible with global cerebral energy failure or with neurotransmitter depletion as responsible for epilepsy in G1D and point to an unknown mechanism by which glycolysis critically regulates cortical excitability.

Original languageEnglish (US)
Pages (from-to)92-101
Number of pages10
JournalNeurobiology of Disease
Volume48
Issue number1
DOIs
StatePublished - Oct 2012

Fingerprint

Acetyl Coenzyme A
Epilepsy
Phenotype
Neurotransmitter Agents
Brain
Ketone Bodies
Citric Acid Cycle
Glucose
Glycolysis
Fatty Acids
Tricarboxylic Acids
Microcephaly
Glutamate-Ammonia Ligase
Facilitative Glucose Transport Proteins
Myelin Sheath
Thalamus
Astrocytes
Cerebral Cortex
Amines
Carbon

Keywords

  • Acetyl-coenzyme A
  • Brain metabolism
  • EEG
  • Epilepsy
  • Fatty acids
  • GABA
  • Glucose transporter
  • GLUT-1
  • GLUT1
  • Glutamate
  • Glutamine
  • Ketones
  • TCA cycle

ASJC Scopus subject areas

  • Neurology

Cite this

Glut1 deficiency (G1D) : Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype. / Marin-Valencia, Isaac; Good, Levi B.; Ma, Qian; Duarte, Joao; Bottiglieri, Teodoro; Sinton, Christopher M.; Heilig, Charles W.; Pascual, Juan M.

In: Neurobiology of Disease, Vol. 48, No. 1, 10.2012, p. 92-101.

Research output: Contribution to journalArticle

Marin-Valencia, I, Good, LB, Ma, Q, Duarte, J, Bottiglieri, T, Sinton, CM, Heilig, CW & Pascual, JM 2012, 'Glut1 deficiency (G1D): Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype', Neurobiology of Disease, vol. 48, no. 1, pp. 92-101. https://doi.org/10.1016/j.nbd.2012.04.011
Marin-Valencia, Isaac ; Good, Levi B. ; Ma, Qian ; Duarte, Joao ; Bottiglieri, Teodoro ; Sinton, Christopher M. ; Heilig, Charles W. ; Pascual, Juan M. / Glut1 deficiency (G1D) : Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype. In: Neurobiology of Disease. 2012 ; Vol. 48, No. 1. pp. 92-101.
@article{73bf5692244c4886943eefc34f8c327e,
title = "Glut1 deficiency (G1D): Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype",
abstract = "Brain glucose supplies most of the carbon required for acetyl-coenzyme A (acetyl-CoA) generation (an important step for myelin synthesis) and for neurotransmitter production via further metabolism of acetyl-CoA in the tricarboxylic acid (TCA) cycle. However, it is not known whether reduced brain glucose transporter type I (GLUT-1) activity, the hallmark of the GLUT-1 deficiency (G1D) syndrome, leads to acetyl-CoA, TCA or neurotransmitter depletion. This question is relevant because, in its most common form in man, G1D is associated with cerebral hypomyelination (manifested as microcephaly) and epilepsy, suggestive of acetyl-CoA depletion and neurotransmitter dysfunction, respectively. Yet, brain metabolism in G1D remains underexplored both theoretically and experimentally, partly because computational models of limited brain glucose transport are subordinate to metabolic assumptions and partly because current hemizygous G1D mouse models manifest a mild phenotype not easily amenable to investigation. In contrast, adult antisense G1D mice replicate the human phenotype of spontaneous epilepsy associated with robust thalamocortical electrical oscillations. Additionally, and in consonance with human metabolic imaging observations, thalamus and cerebral cortex display the lowest GLUT-1 expression and glucose uptake in the mutant mouse. This depletion of brain glucose is associated with diminished plasma fatty acids and elevated ketone body levels, and with decreased brain acetyl-CoA and fatty acid contents, consistent with brain ketone body consumption and with stimulation of brain beta-oxidation and/or diminished cerebral lipid synthesis. In contrast with other epilepsies, astrocyte glutamine synthetase expression, cerebral TCA cycle intermediates, amino acid and amine neurotransmitter contents are also intact in G1D. The data suggest that the TCA cycle is preserved in G1D because reduced glycolysis and acetyl-CoA formation can be balanced by enhanced ketone body utilization. These results are incompatible with global cerebral energy failure or with neurotransmitter depletion as responsible for epilepsy in G1D and point to an unknown mechanism by which glycolysis critically regulates cortical excitability.",
keywords = "Acetyl-coenzyme A, Brain metabolism, EEG, Epilepsy, Fatty acids, GABA, Glucose transporter, GLUT-1, GLUT1, Glutamate, Glutamine, Ketones, TCA cycle",
author = "Isaac Marin-Valencia and Good, {Levi B.} and Qian Ma and Joao Duarte and Teodoro Bottiglieri and Sinton, {Christopher M.} and Heilig, {Charles W.} and Pascual, {Juan M.}",
year = "2012",
month = "10",
doi = "10.1016/j.nbd.2012.04.011",
language = "English (US)",
volume = "48",
pages = "92--101",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Glut1 deficiency (G1D)

T2 - Epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype

AU - Marin-Valencia, Isaac

AU - Good, Levi B.

AU - Ma, Qian

AU - Duarte, Joao

AU - Bottiglieri, Teodoro

AU - Sinton, Christopher M.

AU - Heilig, Charles W.

AU - Pascual, Juan M.

PY - 2012/10

Y1 - 2012/10

N2 - Brain glucose supplies most of the carbon required for acetyl-coenzyme A (acetyl-CoA) generation (an important step for myelin synthesis) and for neurotransmitter production via further metabolism of acetyl-CoA in the tricarboxylic acid (TCA) cycle. However, it is not known whether reduced brain glucose transporter type I (GLUT-1) activity, the hallmark of the GLUT-1 deficiency (G1D) syndrome, leads to acetyl-CoA, TCA or neurotransmitter depletion. This question is relevant because, in its most common form in man, G1D is associated with cerebral hypomyelination (manifested as microcephaly) and epilepsy, suggestive of acetyl-CoA depletion and neurotransmitter dysfunction, respectively. Yet, brain metabolism in G1D remains underexplored both theoretically and experimentally, partly because computational models of limited brain glucose transport are subordinate to metabolic assumptions and partly because current hemizygous G1D mouse models manifest a mild phenotype not easily amenable to investigation. In contrast, adult antisense G1D mice replicate the human phenotype of spontaneous epilepsy associated with robust thalamocortical electrical oscillations. Additionally, and in consonance with human metabolic imaging observations, thalamus and cerebral cortex display the lowest GLUT-1 expression and glucose uptake in the mutant mouse. This depletion of brain glucose is associated with diminished plasma fatty acids and elevated ketone body levels, and with decreased brain acetyl-CoA and fatty acid contents, consistent with brain ketone body consumption and with stimulation of brain beta-oxidation and/or diminished cerebral lipid synthesis. In contrast with other epilepsies, astrocyte glutamine synthetase expression, cerebral TCA cycle intermediates, amino acid and amine neurotransmitter contents are also intact in G1D. The data suggest that the TCA cycle is preserved in G1D because reduced glycolysis and acetyl-CoA formation can be balanced by enhanced ketone body utilization. These results are incompatible with global cerebral energy failure or with neurotransmitter depletion as responsible for epilepsy in G1D and point to an unknown mechanism by which glycolysis critically regulates cortical excitability.

AB - Brain glucose supplies most of the carbon required for acetyl-coenzyme A (acetyl-CoA) generation (an important step for myelin synthesis) and for neurotransmitter production via further metabolism of acetyl-CoA in the tricarboxylic acid (TCA) cycle. However, it is not known whether reduced brain glucose transporter type I (GLUT-1) activity, the hallmark of the GLUT-1 deficiency (G1D) syndrome, leads to acetyl-CoA, TCA or neurotransmitter depletion. This question is relevant because, in its most common form in man, G1D is associated with cerebral hypomyelination (manifested as microcephaly) and epilepsy, suggestive of acetyl-CoA depletion and neurotransmitter dysfunction, respectively. Yet, brain metabolism in G1D remains underexplored both theoretically and experimentally, partly because computational models of limited brain glucose transport are subordinate to metabolic assumptions and partly because current hemizygous G1D mouse models manifest a mild phenotype not easily amenable to investigation. In contrast, adult antisense G1D mice replicate the human phenotype of spontaneous epilepsy associated with robust thalamocortical electrical oscillations. Additionally, and in consonance with human metabolic imaging observations, thalamus and cerebral cortex display the lowest GLUT-1 expression and glucose uptake in the mutant mouse. This depletion of brain glucose is associated with diminished plasma fatty acids and elevated ketone body levels, and with decreased brain acetyl-CoA and fatty acid contents, consistent with brain ketone body consumption and with stimulation of brain beta-oxidation and/or diminished cerebral lipid synthesis. In contrast with other epilepsies, astrocyte glutamine synthetase expression, cerebral TCA cycle intermediates, amino acid and amine neurotransmitter contents are also intact in G1D. The data suggest that the TCA cycle is preserved in G1D because reduced glycolysis and acetyl-CoA formation can be balanced by enhanced ketone body utilization. These results are incompatible with global cerebral energy failure or with neurotransmitter depletion as responsible for epilepsy in G1D and point to an unknown mechanism by which glycolysis critically regulates cortical excitability.

KW - Acetyl-coenzyme A

KW - Brain metabolism

KW - EEG

KW - Epilepsy

KW - Fatty acids

KW - GABA

KW - Glucose transporter

KW - GLUT-1

KW - GLUT1

KW - Glutamate

KW - Glutamine

KW - Ketones

KW - TCA cycle

UR - http://www.scopus.com/inward/record.url?scp=84863827094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863827094&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2012.04.011

DO - 10.1016/j.nbd.2012.04.011

M3 - Article

C2 - 22683290

AN - SCOPUS:84863827094

VL - 48

SP - 92

EP - 101

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -